Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma
Clinical trial NCT07501117 · RECRUITING
Trial details
- NCT number
- NCT07501117
- Sponsor
- Inge Marie Svane
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-29
- Primary completion
- 2029-06-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.